Archive · 2 Oct 2026
Odisha's Sickle Cell Screening Model Gains National Attention
Sickle cell disease and thalassemia are inherited blood disorders that can cause serious health problems.
They are especially difficult to detect in remote and tribal parts of India.
Odisha has created a large program to find these disorders earlier.
Health workers collect a small blood sample on filter paper using DBS-HPLC technology.
The sample can travel to a laboratory without needing complicated refrigeration.
Odisha has screened more than 66 lakh people in 21 districts.
The state says it found 6 lakh sickle-cell carriers and 10,000 people with other haemoglobin variants.
Odisha is now preparing a second phase to screen more people and improve long-term care.
Odisha has completed more than 66 lakh screenings across 21 districts for sickle cell disease and related conditions.
The state reported identifying 6 lakh sickle-cell carriers and 10,000 people with other haemoglobin variants.
Its program combines screening with schools, antenatal care, tribal outreach, counselling, treatment, and follow-up support.
DBS-HPLC technology uses dried blood spots that can be transported without complex cold-chain infrastructure.
Odisha is preparing Phase II of its screening program to expand coverage and strengthen continuity of care.
- Who
- The Government of Odisha and National Health Mission Odisha, with health workers and communities in tribal and high-prevalence districts.
- What
- A large-scale screening, diagnosis, counselling, and treatment-support program for sickle cell disease and thalassemia.
- When
- The program has completed more than 66 lakh screenings; Phase II is now being prepared. India launched its National Sickle Cell Anaemia Elimination Mission in 2023.
- Where
- Across 21 districts of Odisha, including tribal and remote areas.
- Why
- To detect inherited blood disorders earlier, improve access to care, and reduce their long-term public-health burden.
- Screenings completed
- More than 66 lakh across 21 districts of Odisha
- Reported sickle-cell carriers
- 6 lakh individuals
- Other haemoglobin variants
- 10,000 individuals
- Testing technology
- Dried Blood Spot-based High-Performance Liquid Chromatography (DBS-HPLC)
- Phase II objective
- Achieve maximum possible screening across Odisha and strengthen follow-up and continuity of care
- National mission
- India launched the National Sickle Cell Anaemia Elimination Mission in 2023, with a goal of eliminating sickle cell disease as a public-health concern by 2047
- Global burden cited
- Health estimates in the article say India accounts for nearly 14 percent of the world's sickle-cell cases